<DOC>
	<DOCNO>NCT01404169</DOCNO>
	<brief_summary>The objective demonstrate donepezil hydrochloride 10 mg/day superior efficacy compare placebo cognitive function Chinese subject severe Alzheimer 's Disease .</brief_summary>
	<brief_title>A 24-weeks , Multi-center , Randomized , Double-blind , Placebo Controlled Study Evaluate Efficacy Safety Donepezil Hydrochloride Chinese Subjects With Severe Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion Criteria Written inform consent ( IC ) obtain subject ( possible ) subject 's legal guardian legal representative prior begin screen activity . Subject age range : male female subject 50 90 year age , inclusive Diagnosis : diagnostic evidence probable Alzheimer 's Disease ( AD ) consistent Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) National Institute Neurological Communicative Disorders StrokeAlzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) criteria MMSE 1 12 inclusive , Screening Baseline SIB less equal 90 great equal 10 Screening Baseline Comorbid medical condition must clinically stable prior Baseline , unless otherwise specify . Exclusion Criteria Subjects know history disorder affect cognition ability ass cognition , distinguishable AD Evidence focal disease account dementia cranial image MRI CT . Subjects dementia complicate organic disease AD delirium accord DSMIV criterion Subjects swallow difficulty swallow whole tablet , tablet break crush Illiteracy prior AD Subjects unwilling unable fulfill requirement study Treatment another cholinesterase inhibitor and/or memantine 3 month prior Screening Subjects poor response ( tolerability ) prior exposure donepezil</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Alzheimer Disease</keyword>
	<keyword>Dementia</keyword>
	<keyword>Delirium</keyword>
	<keyword>Amnestic</keyword>
	<keyword>Cognitive Disorders</keyword>
	<keyword>Donepezil</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Tauopathies</keyword>
	<keyword>Neurodegenerative Diseases</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Cholinesterase Inhibitors</keyword>
	<keyword>Enzy</keyword>
</DOC>